Overview
A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p733)
Indication
For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions
Associated Conditions
- Dermatosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Teligent Pharma, Inc. | 52565-017 | TOPICAL | 0.5 mg in 1 g | 9/10/2019 | |
| Almirall, LLC | 16110-052 | TOPICAL | 0.5 mg in 1 mL | 7/5/2018 | |
| Almirall, LLC | 16110-034 | TOPICAL | 0.25 mg in 1 g | 1/13/2023 | |
| Bryant Ranch Prepack | 72162-1439 | TOPICAL | 0.5 mg in 1 mL | 8/17/2023 | |
| Almirall, LLC | 16110-587 | TOPICAL | 4 ug in 1 cm2 | 9/27/2019 | |
| Almirall, LLC | 16110-035 | TOPICAL | 0.5 mg in 1 g | 1/13/2023 | |
| Padagis Israel Pharmaceuticals Ltd | 45802-928 | TOPICAL | 0.5 mg in 1 mL | 10/11/2022 | |
| Taro Pharmaceuticals U.S.A., Inc. | 51672-5301 | TOPICAL | 0.5 mg in 1 g | 4/28/2016 | |
| Allergan, Inc. | 0023-5870 | TOPICAL | 4 ug in 1 cm2 | 12/13/2019 | |
| INA Pharmaceutics, Inc | 74157-130 | TOPICAL | 0.5 mg in 1 g | 7/7/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| DRENISON TAPE M 170 4MCG SQ CM | eli lilly canada inc | 00128724 | Tape - Topical | 4 MCG / SQ CM | 12/31/1969 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.